Improving early detection of breast and cervical cancers in Kenya
An Integrated Community Clinic Model of Optimized Implementation Strategies to Increase Early Detection of Breast and Cervical Cancers in Kenya
This study is testing new ways to help women in Kenya, aged 30 to 55, get screened for breast and cervical cancers earlier so they can catch these diseases sooner and get the treatment they need.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 5400 (estimated) |
| Ages | 30 Years to 55 Years |
| Sex | Female |
| Sponsor | Implenomics Academic / other |
| Locations | 1 site (Machakos) |
| Trial ID | NCT06572774 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance the early detection of breast and cervical cancers in Kenya, where late-stage diagnoses are common. It will evaluate the effectiveness and cost-effectiveness of multicomponent strategies designed to increase cancer screening uptake among women aged 30 to 55. The study will implement community health volunteer-led education and practice facilitation to improve awareness and access to screening services. By conducting a pragmatic cluster randomized trial, the researchers will assess screening outcomes, including uptake, diagnostic test completion, and treatment initiation.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 30 to 55 who are eligible for breast and cervical cancer screening and are not experiencing any symptoms of these cancers.
Not a fit: Patients who are currently pregnant or experiencing symptoms of breast or cervical cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly reduce breast and cervical cancer mortality rates by increasing early detection through improved screening access.
How similar studies have performed: Other studies have shown success with community-based interventions to improve cancer screening rates, indicating that this approach has potential for effectiveness.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women will be eligible to participate if they are 30 to 55 years old, due to receive both breast and cervical cancer screening during the study intervention implementation phase based on Kenyan guideline recommendations, not experiencing breast or cervical cancer symptoms (will be referred for diagnostic testing with facilitation support from the study team), not pregnant, fluent in a study language (English,Kiswahili, Kamba, Kalenjin, and Kikuyu) and plan to remain in the community for at least 2 years Exclusion Criteria: -
Where this trial is running
Machakos
- Public Health Facilities in Machakos, Nyeri and Nakuru — Machakos, Kenya (Recruiting)
Study contacts
- Study coordinator: Sujha Subramanian
- Email: sujha.subramanian@implenomics.com
- Phone: 3022225034
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.